{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05756764",
            "orgStudyIdInfo": {
                "id": "U24DK132740-5053"
            },
            "secondaryIdInfos": [
                {
                    "id": "U24DK132740",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/U24DK132740"
                }
            ],
            "organization": {
                "fullName": "Louisiana State University Health Sciences Center in New Orleans",
                "class": "OTHER"
            },
            "briefTitle": "Anti-obesity Pharmacotherapy and Inflammation",
            "officialTitle": "Pilot Study of the Effect of Weight Loss by Pharmacotherapy on Chronic Pro-tumor Inflammatory Cells",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "anti-obesity-pharmacotherapy-and-inflammation"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-06-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03-20",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-02-23",
            "studyFirstSubmitQcDate": "2023-03-03",
            "studyFirstPostDateStruct": {
                "date": "2023-03-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Maria Sanchez-Pino, Ph.D.",
                "investigatorTitle": "Assistant Professor",
                "investigatorAffiliation": "Louisiana State University Health Sciences Center in New Orleans"
            },
            "leadSponsor": {
                "name": "Louisiana State University Health Sciences Center in New Orleans",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Tulane University",
                    "class": "OTHER"
                },
                {
                    "name": "Pennington Biomedical Research Center",
                    "class": "OTHER"
                },
                {
                    "name": "Ochsner Health System",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This study evaluates the relationship between weight loss, circulating inflammatory markers and lipids from 24 patients before and after 6 months of pharmacotherapy as a standard of care for anti-obesity treatment",
            "detailedDescription": "This study aims to determine if weight loss by pharmacotherapy with liraglutide, semaglutide, or phentermine-topiramate promotes the reduction of pro-tumoral inflammatory cells Myeloid-derived suppressor cells (MDSC), simultaneously to the improvement of lipid profile (LDL-Cholesterol, HDL-Cholesterol, triglycerides, and free fatty acids) and concentration in the blood.\n\nLiraglutide, semaglutide, and phentermine-topiramate are FDA-approved medications to treat obesity and obesity-associated comorbidities.\n\nTwenty-four patients undergoing standard of care for anti-obesity treatment at VA Medical Center, and Tulane Center for Clinical Research (TCCR) will be recruited before initiation of pharmacotherapy as part of their standard of care and followed up to 6 months to compare the primary study variables."
        },
        "conditionsModule": {
            "conditions": [
                "Obesity"
            ],
            "keywords": [
                "Inflammation",
                "Dyslipidemia",
                "Metabolic syndrome"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "Whole blood will be obtained from participant subjects. Collection of serum, plasma, and isolation of leukocytes will be used for study aims and storage (-80 degrees)."
            },
            "enrollmentInfo": {
                "count": 24,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Patients with obesity on pharmacotherapy",
                    "description": "Before initiation of pharmacotherapy (as part of the standard-of-care treatment) and 6 months after initiated medication",
                    "interventionNames": [
                        "Drug: Semaglutide",
                        "Drug: Phentermine-Topiramate combination",
                        "Drug: Phentermine",
                        "Drug: Tirzepatide",
                        "Drug: Topiramate",
                        "Drug: Diethylpropion",
                        "Drug: Naltrexone/Bupropion",
                        "Drug: Liraglutide"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Semaglutide",
                    "description": "Medication for weight loss",
                    "armGroupLabels": [
                        "Patients with obesity on pharmacotherapy"
                    ],
                    "otherNames": [
                        "Glucagon-like peptide-1 receptor (GLP1-R) agonist",
                        "Wegovy"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Phentermine-Topiramate combination",
                    "description": "Medication for weight loss",
                    "armGroupLabels": [
                        "Patients with obesity on pharmacotherapy"
                    ],
                    "otherNames": [
                        "Qsymia"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Phentermine",
                    "description": "Medication for weight loss",
                    "armGroupLabels": [
                        "Patients with obesity on pharmacotherapy"
                    ],
                    "otherNames": [
                        "Lomaira",
                        "Adipex-P"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Tirzepatide",
                    "description": "Medication for weight loss",
                    "armGroupLabels": [
                        "Patients with obesity on pharmacotherapy"
                    ],
                    "otherNames": [
                        "Mounjaro",
                        "Zepbound",
                        "GIP/GLP-1 RA"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Topiramate",
                    "description": "Medication for weight loss",
                    "armGroupLabels": [
                        "Patients with obesity on pharmacotherapy"
                    ],
                    "otherNames": [
                        "Topamax",
                        "Trokendi XR",
                        "Qudexy XR"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Diethylpropion",
                    "description": "Medication for weight loss",
                    "armGroupLabels": [
                        "Patients with obesity on pharmacotherapy"
                    ],
                    "otherNames": [
                        "Tenuate",
                        "Diethylcathinone"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Naltrexone/Bupropion",
                    "description": "Medication for weight loss",
                    "armGroupLabels": [
                        "Patients with obesity on pharmacotherapy"
                    ],
                    "otherNames": [
                        "Contrave"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Liraglutide",
                    "description": "Medication for weight loss",
                    "armGroupLabels": [
                        "Patients with obesity on pharmacotherapy"
                    ],
                    "otherNames": [
                        "Saxenda",
                        "Victoza",
                        "Glucagon-like peptide-1 receptor (GLP1-R) agonist"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "weight loss",
                    "description": "Weight Loss Percentage (Pounds lost divided by starting weight (in pounds) multiplied by 100)",
                    "timeFrame": "baseline and 24 weeks"
                },
                {
                    "measure": "MDSC in peripheral blood",
                    "description": "Changes in number of MDSC in blood",
                    "timeFrame": "baseline and 24 weeks"
                },
                {
                    "measure": "Levels of lipids in circulation",
                    "description": "Changes in concentration (mg/dL) of each type of lipids: LDL-Cholesterol, triglycerides, and free fatty acids",
                    "timeFrame": "baseline and 24 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Systemic inflammation measured by C-reactive protein levels",
                    "description": "Changes in concentration (mg/L) of C-reactive protein in serum",
                    "timeFrame": "baseline and 24 weeks"
                },
                {
                    "measure": "Systemic inflammation measured by adipokines levels in circulation",
                    "description": "Changes in concentration (pg/mL) of interleukin 6 (IL-6), tumor-necrosis factor alpha (TNFa) and leptin in plasma",
                    "timeFrame": "baseline and 24 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Body mass index (BMI): over 30 kg/m2\n* Age: 35 to 60 years old\n\nExclusion Criteria:\n\n* Taking medications with anti-inflammatory properties like glucocorticoids, prednisone, or non-steroidal anti-inflammatory medications, such as aspirin or Motrin Subjects on medications for long-term weight management such as phentermine-topiramate (Qsymia), orlistat (Xenical), naltrexone-bupropion (Contrave), and the glucagon-like peptide-1 receptor agonists such as liraglutide (Saxenda), and semaglutide (Wegovy).\n* Prior history of cancer\n* Having any clinical symptoms of systemic inflammation, acute infections such as Coronavirus disease 2019, or chronic diseases such as cancer, tuberculosis, autoimmune disease, and AIDS\n* An adult unable to consent\n* Prisoner\n* Pregnancy or breastfeeding women",
            "sex": "ALL",
            "minimumAge": "35 Years",
            "maximumAge": "60 Years",
            "stdAges": [
                "ADULT"
            ],
            "studyPopulation": "Patients with obesity, defined as having a body mass index (BMI) \\> 30, from New Orleans and its surroundings, scheduled for initiating the anti-obesity treatment with drugs for weight loss as part of their standard-of-care for anti-obesity treatment at Clinics from New Orleans and its surroundings; therefore, the research trial team will not provide the medications. Expect to recruit 50% African American (6 women, 6 men), and 50% White American (6 women, 6 men), as a representative majority of the New Orleans population.",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Maria D Sanchez-Pino, Ph.D.",
                    "role": "CONTACT",
                    "phone": "5042102831",
                    "email": "msanc2@lsuhsc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Maria D Sanchez-Pino, Ph.D.",
                    "affiliation": "LSU-Health Sciences Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO",
                    "status": "RECRUITING",
                    "city": "New Orleans",
                    "state": "Louisiana",
                    "zip": "70112",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Maria D Sanchez-Pino, Ph.D.",
                            "role": "CONTACT",
                            "phone": "504-210-2831",
                            "email": "msanc2@lsuhsc.edu"
                        },
                        {
                            "name": "Vivian Fonseca, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Justin Brown, Ph.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Mary Meyaski-Schluter, Nurse",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Maria D Sanchez-Pino, Ph.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Virginia Garrison, Nurse",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.95465,
                        "lon": -90.07507
                    }
                },
                {
                    "facility": "Ochsner Health System - Biospecimen",
                    "status": "RECRUITING",
                    "city": "New Orleans",
                    "state": "Louisiana",
                    "zip": "70121",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Melyssa Bratton, Ph.D.",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.95465,
                        "lon": -90.07507
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "The investigators will adhere to the NIH Grants Policy on Sharing of Unique Research Resources, including the Sharing of Biomedical Research Resources: Guidelines for Recipients of NIH Grants and Contracts on Obtaining and Disseminating Biomedical Research Resources (NOT-OD-21-013).\n\nData dictionaries, statistical analysis code, and de-identified data may be deposited for sharing. Data may include demographic, clinical, anthropometric, outcome measures, and other relevant variables, as allowed by the data-owning organization, consistent with applicable laws and regulations.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF",
                "CSR",
                "ANALYTIC_CODE"
            ],
            "timeFrame": "Data may be deposited into the repository no later than within one year of completing the study period for the award or upon acceptance of the data for publication or public disclosure of study results.",
            "accessCriteria": "Deidentified data and supporting information may be shared with investigators and research staff working under a Federal Wide Assurance (FWA) institution and could be used for secondary study purposes after approval of the local Institutional Review Board (IRB)"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009765",
                    "term": "Obesity"
                }
            ],
            "ancestors": [
                {
                    "id": "D000050177",
                    "term": "Overweight"
                },
                {
                    "id": "D000044343",
                    "term": "Overnutrition"
                },
                {
                    "id": "D000009748",
                    "term": "Nutrition Disorders"
                },
                {
                    "id": "D000001835",
                    "term": "Body Weight"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M23005",
                    "name": "Metabolic Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M5114",
                    "name": "Body Weight",
                    "relevance": "LOW"
                },
                {
                    "id": "M10293",
                    "name": "Inflammation",
                    "relevance": "LOW"
                },
                {
                    "id": "M12701",
                    "name": "Obesity",
                    "asFound": "Obesity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26181",
                    "name": "Dyslipidemias",
                    "relevance": "LOW"
                },
                {
                    "id": "M18102",
                    "name": "Weight Loss",
                    "relevance": "LOW"
                },
                {
                    "id": "M26186",
                    "name": "Overweight",
                    "relevance": "LOW"
                },
                {
                    "id": "M25307",
                    "name": "Overnutrition",
                    "relevance": "LOW"
                },
                {
                    "id": "M12684",
                    "name": "Nutrition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000591245",
                    "term": "Semaglutide"
                },
                {
                    "id": "D000069450",
                    "term": "Liraglutide"
                },
                {
                    "id": "D000077236",
                    "term": "Topiramate"
                },
                {
                    "id": "D000010645",
                    "term": "Phentermine"
                },
                {
                    "id": "D000004053",
                    "term": "Diethylpropion"
                },
                {
                    "id": "D000009271",
                    "term": "Naltrexone"
                },
                {
                    "id": "D000016642",
                    "term": "Bupropion"
                },
                {
                    "id": "D000005934",
                    "term": "Glucagon"
                },
                {
                    "id": "D000052216",
                    "term": "Glucagon-Like Peptide 1"
                },
                {
                    "id": "C000629749",
                    "term": "Tirzepatide"
                }
            ],
            "ancestors": [
                {
                    "id": "D000097789",
                    "term": "Glucagon-Like Peptide-1 Receptor Agonists"
                },
                {
                    "id": "D000007004",
                    "term": "Hypoglycemic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000427",
                    "term": "Alcohol Deterrents"
                },
                {
                    "id": "D000009292",
                    "term": "Narcotic Antagonists"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000054795",
                    "term": "Incretins"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000018687",
                    "term": "Antidepressive Agents, Second-Generation"
                },
                {
                    "id": "D000000928",
                    "term": "Antidepressive Agents"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                },
                {
                    "id": "D000018765",
                    "term": "Dopamine Uptake Inhibitors"
                },
                {
                    "id": "D000014179",
                    "term": "Neurotransmitter Uptake Inhibitors"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000015259",
                    "term": "Dopamine Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000065690",
                    "term": "Cytochrome P-450 CYP2D6 Inhibitors"
                },
                {
                    "id": "D000065607",
                    "term": "Cytochrome P-450 Enzyme Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000000927",
                    "term": "Anticonvulsants"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000000697",
                    "term": "Central Nervous System Stimulants"
                },
                {
                    "id": "D000001067",
                    "term": "Appetite Depressants"
                },
                {
                    "id": "D000019440",
                    "term": "Anti-Obesity Agents"
                },
                {
                    "id": "D000013566",
                    "term": "Sympathomimetics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9043",
                    "name": "Glucagon",
                    "asFound": "Before surgery",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26997",
                    "name": "Glucagon-Like Peptide 1",
                    "asFound": "Natural Killer Cells",
                    "relevance": "HIGH"
                },
                {
                    "id": "M353561",
                    "name": "Semaglutide",
                    "asFound": "Stretching",
                    "relevance": "HIGH"
                },
                {
                    "id": "M204206",
                    "name": "Tirzepatide",
                    "asFound": "DISKUS",
                    "relevance": "HIGH"
                },
                {
                    "id": "M419",
                    "name": "Liraglutide",
                    "asFound": "Place",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1711",
                    "name": "Topiramate",
                    "asFound": "Infiltration",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12222",
                    "name": "Naltrexone",
                    "asFound": "Closure",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19013",
                    "name": "Bupropion",
                    "asFound": "Apnea",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13550",
                    "name": "Phentermine",
                    "asFound": "Immunohistochemistry",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7242",
                    "name": "Diethylpropion",
                    "asFound": "3 classes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3401",
                    "name": "Glucagon-Like Peptide-1 Receptor Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M10054",
                    "name": "Hypoglycemic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M3777",
                    "name": "Ethanol",
                    "relevance": "LOW"
                },
                {
                    "id": "M12245",
                    "name": "Narcotics",
                    "relevance": "LOW"
                },
                {
                    "id": "M12243",
                    "name": "Narcotic Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M27905",
                    "name": "Incretins",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M4247",
                    "name": "Antidepressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                },
                {
                    "id": "M7473",
                    "name": "Dopamine",
                    "relevance": "LOW"
                },
                {
                    "id": "M20832",
                    "name": "Dopamine Uptake Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M17962",
                    "name": "Dopamine Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M30537",
                    "name": "Cytochrome P-450 Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4246",
                    "name": "Anticonvulsants",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4029",
                    "name": "Central Nervous System Stimulants",
                    "relevance": "LOW"
                },
                {
                    "id": "M4379",
                    "name": "Appetite Depressants",
                    "relevance": "LOW"
                },
                {
                    "id": "M21396",
                    "name": "Anti-Obesity Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M16345",
                    "name": "Sympathomimetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "AntiConv",
                    "name": "Anticonvulsants"
                },
                {
                    "abbrev": "AlcDet",
                    "name": "Alcohol Deterrents"
                },
                {
                    "abbrev": "NarcAntag",
                    "name": "Narcotic Antagonists"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "AnObAg",
                    "name": "Anti-Obesity Agents"
                },
                {
                    "abbrev": "CNSSti",
                    "name": "Central Nervous System Stimulants"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CaAg",
                    "name": "Cardiotonic Agents"
                }
            ]
        }
    },
    "hasResults": false
}